Pulmonx Corp (LUNG)

R&D Expense Growth

2.76%

Quarterly · Period ending:

LUNG logo

LUNG R&D Expense Growth

Latest reported2.76%
LUNG Quarterly R&D Growth (QoQ) (0.00% → 2.76%)
High-resolution chart · PNG

LUNG r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Pulmonx Corp R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
2.7557%
6.895%
-5.4272%
-8.6694%
11.5643%
18.8703%
6.8643%
-33.3215%
33.3729%
8.0595%
-7.6777%
-26.0946%
34.2582%
8.9675%
-10.6047%
21.4802%
1.6978%
-4.6926%
31.7229%
-19.7091%
15.557%
22.7346%
23.7857%
40.0421%
-8.8818%
-2.3706%
14.5818%
-3.6501%
-4.6931%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.